Pluri Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Pluri Inc. (PLUR) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $35.00 million as of 2025-12-31, per its 10-Q filed 2026-02-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2026-02-12
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $35.00M.
- 2024-11-25: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $2.50M.
- 2024-05-28: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $2.50M.
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
|---|---|
| 2025-12-31 | $35.00M 10-Q · filed 2026-02-12 |
| 2024-11-25 | $2.50M 10-Q · filed 2025-05-13 |
| 2024-05-28 | $2.50M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $0.00 10-K · filed 2023-09-12 |
| 2016-12-31 | $294.00K 10-Q · filed 2017-02-08 |
| 2016-09-30 | $357.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $260.00K 10-K · filed 2016-09-07 |
| 2016-03-31 | $382.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $451.00K 10-Q · filed 2016-02-08 |
| 2015-09-30 | $451.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $768.00K 10-K · filed 2015-09-09 |
| 2015-03-31 | $895.00K 10-Q · filed 2015-05-06 |
| 2014-12-31 | $778.00K 10-Q · filed 2015-02-05 |
| 2014-09-30 | $929.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $1.05M 10-K · filed 2014-09-11 |
| 2014-03-31 | $1.46M 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |